An ultra-stable single-chain insulin analog resists thermal inactivation and exhibits biological signaling duration equivalent to the native protein
暂无分享,去创建一个
F. Ismail-Beigi | M. Lawrence | M. Weiss | N. Rege | N. Phillips | V. Yee | Yi Peng | Michael D. Glidden | Nalinda P. Wickramasinghe | Yen-Shan Chen | J. Whittaker | Yanwu Yang | Mamuni Swain | Khadijah Aldabbagh | Kelley Carr | M. Phillips
[1] Brian J. Smith,et al. Solution structure of an ultra-stable single-chain insulin analog connects protein dynamics to a novel mechanism of receptor binding , 2017, The Journal of Biological Chemistry.
[2] R. Beaser,et al. Insulin: Making Sense of Current Options. , 2016, Endocrinology and metabolism clinics of North America.
[3] M. Lawrence,et al. Contribution of TyrB26 to the Function and Stability of Insulin , 2016, The Journal of Biological Chemistry.
[4] J. Mayer,et al. Pursuit of a perfect insulin , 2016, Nature Reviews Drug Discovery.
[5] J. Carpenter,et al. Characterization of Sizes of Aggregates of Insulin Analogs and the Conformations of the Constituent Protein Molecules: A Concomitant Dynamic Light Scattering and Raman Spectroscopy Study. , 2016, Journal of pharmaceutical sciences.
[6] J. Menting,et al. Structural Congruency of Ligand Binding to the Insulin and Insulin/Type 1 Insulin-like Growth Factor Hybrid Receptors. , 2015, Structure.
[7] R. Bergenstal,et al. Initiation of human regular U-500 insulin use is associated with improved glycemic control: a real-world US cohort study , 2015, BMJ Open Diabetes Research and Care.
[8] T. Pedersen,et al. Treatment of Diabetic Rats With Insulin or a Synthetic Insulin Receptor Agonist Peptide Leads to Divergent Metabolic Responses , 2014, Diabetes.
[9] Brian J. Smith,et al. Protective hinge in insulin opens to enable its receptor engagement , 2014, Proceedings of the National Academy of Sciences.
[10] F. Ismail-Beigi,et al. Biophysical Optimization of a Therapeutic Protein by Nonstandard Mutagenesis , 2014, The Journal of Biological Chemistry.
[11] J. Mayer,et al. Chemical synthesis of insulin analogs through a novel precursor. , 2014, ACS chemical biology.
[12] D. Leroith,et al. Insulin Receptor Phosphorylation by Endogenous Insulin or the Insulin Analog AspB10 Promotes Mammary Tumor Growth Independent of the IGF-I Receptor , 2013, Diabetes.
[13] M. Weiss. Design of ultra-stable insulin analogues for the developing world , 2013 .
[14] U. Ribel,et al. Insulin analog with additional disulfide bond has increased stability and preserved activity , 2013, Protein science : a publication of the Protein Society.
[15] Andrzej M. Brzozowski,et al. How insulin engages its primary binding site on the insulin receptor , 2013, Nature.
[16] B. Blagoev,et al. Agonism and Antagonism at the Insulin Receptor , 2012, PloS one.
[17] J. Johansson,et al. Insulin solubility transitions by pH‐dependent interactions with proinsulin C‐peptide , 2012, The FEBS journal.
[18] Rebeccah L. Brown,et al. Clinical Use of U-500 Regular Insulin: Review and Meta-Analysis , 2012, Journal of diabetes science and technology.
[19] F. Ismail-Beigi,et al. Insulin Fibrillation and Protein Design: Topological Resistance of Single-Chain Analogs to Thermal Degradation with Application to a Pump Reservoir , 2012, Journal of diabetes science and technology.
[20] L. Sciacca,et al. Insulin Analogs and Cancer , 2012, Front. Endocrin..
[21] A. Palmer,et al. Measuring steady-state and dynamic endoplasmic reticulum and Golgi Zn2+ with genetically encoded sensors , 2011, Proceedings of the National Academy of Sciences.
[22] Randy J. Read,et al. Overview of the CCP4 suite and current developments , 2011, Acta crystallographica. Section D, Biological crystallography.
[23] B. Bode. Comparison of pharmacokinetic properties, physicochemical stability, and pump compatibility of 3 rapid-acting insulin analogues-aspart, lispro, and glulisine. , 2011, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[24] R. Lefkowitz,et al. Therapeutic potential of β-arrestin- and G protein-biased agonists. , 2011, Trends in molecular medicine.
[25] R. Tycko,et al. An Achilles' Heel in an Amyloidogenic Protein and Its Repair , 2010, The Journal of Biological Chemistry.
[26] Wolfgang Kabsch,et al. Integration, scaling, space-group assignment and post-refinement , 2010, Acta crystallographica. Section D, Biological crystallography.
[27] Vincent B. Chen,et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution , 2010, Acta crystallographica. Section D, Biological crystallography.
[28] M. Granvik,et al. Insulin crystallization depends on zinc transporter ZnT8 expression, but is not required for normal glucose homeostasis in mice , 2009, Proceedings of the National Academy of Sciences.
[29] M. Oleksiewicz,et al. MCF‐7 human mammary adenocarcinoma cells exhibit augmented responses to human insulin on a collagen IV surface , 2009, Journal of applied toxicology : JAT.
[30] M. Weiss,et al. Enhancing the Activity of a Protein by Stereospecific Unfolding , 2009, Journal of Biological Chemistry.
[31] D. Cyranoski. Retracted paper rattles Korean science , 2009, Nature.
[32] L. Thim,et al. Single chain des-(B30) insulin. Intramolecular crosslinking of insulin by trypsin catalyzed transpeptidation. , 2009, International journal of peptide and protein research.
[33] M. Weiss,et al. ENHANCING THE ACTIVITY OF INSULIN BY STEREOSPECIFIC UNFOLDING , 2008 .
[34] J. Cregg,et al. Posttransformational vector amplification in the yeast Pichia pastoris. , 2008, FEMS yeast research.
[35] Kun Huang,et al. Design of an Active Ultrastable Single-chain Insulin Analog , 2008, Journal of Biological Chemistry.
[36] J. Wallace,et al. Structure and functional analysis of the IGF‐II/IGF2R interaction , 2008, The EMBO journal.
[37] Randy J. Read,et al. Phaser crystallographic software , 2007, Journal of applied crystallography.
[38] T. Bartels,et al. Insulin Glulisine—A Comprehensive Preclinical Evaluation , 2006, International journal of toxicology.
[39] P. Carey,et al. Proinsulin Is Refractory to Protein Fibrillation , 2005, Journal of Biological Chemistry.
[40] V. Besada,et al. Multiple gene copy number enhances insulin precursor secretion in the yeast Pichia pastoris , 2005, Biotechnology Letters.
[41] Kun Huang,et al. Enhancing the activity of insulin at the receptor interface: crystal structure and photo-cross-linking of A8 analogues. , 2004, Biochemistry.
[42] Gavin Brooks,et al. Cell Cycle Control , 2004, Methods in Molecular Biology™.
[43] Daniela Barlocco. Insulin glulisine. Aventis Pharma. , 2003, Current opinion in investigational drugs.
[44] W. Pangborn,et al. The structure of T6 human insulin at 1.0 A resolution. , 2003, Acta crystallographica. Section D, Biological crystallography.
[45] J. Whittaker,et al. Structural biology of insulin and IGF1 receptors: implications for drug design , 2002, Nature Reviews Drug Discovery.
[46] Z. Dauter,et al. Structural origins of the functional divergence of human insulin-like growth factor-I and insulin. , 2002, Biochemistry.
[47] Christopher M. Dobson,et al. The protofilament structure of insulin amyloid fibrils , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[48] Ashley J. Wilson,et al. Insulin at pH 2: structural analysis of the conditions promoting insulin fibre formation. , 2002, Journal of molecular biology.
[49] N. Kaarsholm,et al. Expression of Insulin in Yeast: The Importance of Molecular Adaptation for Secretion and Conversion , 2001, Biotechnology & genetic engineering reviews.
[50] V. Uversky,et al. Effect of environmental factors on the kinetics of insulin fibril formation: elucidation of the molecular mechanism. , 2001, Biochemistry.
[51] Y Wang,et al. Human insulin from a precursor overexpressed in the methylotrophic yeast Pichia pastoris and a simple procedure for purifying the expression product. , 2001, Biotechnology and bioengineering.
[52] J. Sambrook,et al. Molecular Cloning: A Laboratory Manual , 2001 .
[53] S. M. Setter,et al. Insulin Aspart: A New Rapid-Acting Insulin Analog , 2000, The Annals of pharmacotherapy.
[54] Y. Sanejouand,et al. Building‐block approach for determining low‐frequency normal modes of macromolecules , 2000, Proteins.
[55] T. Kjeldsen,et al. Yeast secretory expression of insulin precursors , 2000, Applied Microbiology and Biotechnology.
[56] A. Saltiel,et al. Signaling pathways in insulin action: molecular targets of insulin resistance. , 2000, The Journal of clinical investigation.
[57] T. Kjeldsen,et al. Secretory expression and characterization of insulin in Pichia pastoris , 1999, Biotechnology and applied biochemistry.
[58] Y. Chiu,et al. FDA perspective on peptide formulation and stability issues. , 1998, Journal of pharmaceutical sciences.
[59] F. Ismail-Beigi,et al. Glycemia-lowering effect of cobalt chloride in the diabetic rat: role of decreased gluconeogenesis. , 1998, American journal of physiology. Endocrinology and metabolism.
[60] D. Steiner,et al. The role of assembly in insulin's biosynthesis. , 1998, Current opinion in structural biology.
[61] M. Weiss,et al. Mini-proinsulin and mini-IGF-I: homologous protein sequences encoding non-homologous structures. , 1998, Journal of molecular biology.
[62] J. Brange,et al. Toward understanding insulin fibrillation. , 1997, Journal of pharmaceutical sciences.
[63] M. Weiss,et al. Mapping the functional surface of insulin by design: structure and function of a novel A-chain analogue. , 1996, Journal of molecular biology.
[64] N. Kaarsholm,et al. Solution structure of an engineered insulin monomer at neutral pH. , 1996, Biochemistry.
[65] A. Stern,et al. Structure and Dynamics of a Protein Assembly.1H-NMR Studies of the 36 kDaR6Insulin Hexamer , 1996 .
[66] Z. X. Wang,et al. An exact mathematical expression for describing competitive binding of two different ligands to a protein molecule , 1995, FEBS letters.
[67] L. Schäffer,et al. A single-chain insulin-like growth factor I/insulin hybrid binds with high affinity to the insulin receptor. , 1995, The Biochemical journal.
[68] P. Arvan,et al. Formation of the insulin-containing secretory granule core occurs within immature beta-granules. , 1994, The Journal of biological chemistry.
[69] S. Shoelson,et al. Receptor binding redefined by a structural switch in a mutant human insulin , 1994, Nature.
[70] E J Dodson,et al. Role of B13 Glu in insulin assembly. The hexamer structure of recombinant mutant (B13 Glu-->Gln) insulin. , 1992, Journal of molecular biology.
[71] P. Katsoyannis,et al. The A14 position of insulin tolerates considerable structural alterations with modest effects on the biological behavior of the hormone , 1992, Journal of protein chemistry.
[72] B H Frank,et al. Altering the association properties of insulin by amino acid replacement. , 1992, Protein engineering.
[73] D. Howey,et al. Biosynthetic Human Proinsulin: Review of Chemistry, in Vitro and in Vivo Receptor Binding, Animal and Human Pharmacology Studies, and Clinical Trial Experience , 1992, Diabetes Care.
[74] E J Dodson,et al. X-ray analysis of the single chain B29-A1 peptide-linked insulin molecule. A completely inactive analogue. , 1991, Journal of molecular biology.
[75] Z. Dauter,et al. X-ray structure of an unusual Ca2+ site and the roles of Zn2+ and Ca2+ in the assembly, stability, and storage of the insulin hexamer. , 1991, Biochemistry.
[76] R. Mirmira,et al. Importance of the character and configuration of residues B24, B25, and B26 in insulin-receptor interactions. , 1991, The Journal of biological chemistry.
[77] Robert T. Sauer,et al. Reverse hydrophobic effects relieved by amino-acid substitutions at a protein surface , 1990, Nature.
[78] K. Makino,et al. Cloning, nucleotide sequence, and expression of Achromobacter protease I gene. , 1989, The Journal of biological chemistry.
[79] E. Dodson,et al. Phenol stabilizes more helix in a new symmetrical zinc insulin hexamer , 1989, Nature.
[80] H. Tager,et al. Perturbation of insulin-receptor interactions by intramolecular hormone cross-linking. Analysis of relative movement among residues A1, B1, and B29. , 1989, The Journal of biological chemistry.
[81] T L Blundell,et al. The structure of 2Zn pig insulin crystals at 1.5 A resolution. , 1988, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.
[82] I. S. Johnson. Human insulin from recombinant DNA technology. , 1983, Science.
[83] K. Inouye,et al. Semisynthesis and properties of some insulin analogs , 1981, Biopolymers.
[84] D. Hodgkin,et al. Evidence concerning insulin activity from the structure of a cross-linked derivative. , 1981, Hoppe-Seyler's Zeitschrift fur physiologische Chemie.
[85] E. Rinderknecht,et al. The amino acid sequence of human insulin-like growth factor I and its structural homology with proinsulin. , 1978, The Journal of biological chemistry.
[86] D. Steiner. On the Role of the Proinsulin C-peptide , 1978, Diabetes.
[87] D. Steiner,et al. Insulin Biosynthesis: Evidence for a Precursor , 1967, Science.
[88] D. F. Waugh. A mechanism for the formation of fibrils from protein molecules. , 1957, Journal of cellular physiology. Supplement.
[89] M. Horne,et al. Down-regulation of cyclin G2 by insulin, IGF-I (insulin-like growth factor 1) and X10 (AspB10 insulin): role in mitogenesis. , 2014, The Biochemical journal.
[90] Shamim Ahmad. Diabetes : an old disease, a new insight , 2012 .
[91] Emil Ginter,et al. Type 2 diabetes mellitus, pandemic in 21st century. , 2012, Advances in experimental medicine and biology.
[92] D. M. Robinson,et al. Insulin Glulisine , 2012, Drugs.
[93] N. Seidah,et al. Proprotein Convertases , 2011, Methods in Molecular Biology.
[94] J. Wade,et al. The human insulin superfamily of polypeptide hormones. , 2009, Vitamins and hormones.
[95] R. Chance,et al. Insulin self-association and the relationship to pharmacokinetics and pharmacodynamics. , 2001, Critical reviews in therapeutic drug carrier systems.
[96] T. Sosnick,et al. Application of circular dichroism to study RNA folding transitions. , 2000, Methods in enzymology.
[97] D. Steiner,et al. Insulin Through the Ages : Phylogeny of a Growth Promoting and Metabolic Regulatory Hormone , 2000 .
[98] Kevin L. Shaw,et al. Linear extrapolation method of analyzing solvent denaturation curves , 2000, Proteins.
[99] J. Brange,et al. Insulin formulation and delivery. , 1997, Pharmaceutical biotechnology.
[100] A. Stern,et al. Structure and dynamics of a protein assembly. 1H-NMR studies of the 36 kDa R6 insulin hexamer. , 1996, Journal of molecular biology.
[101] B. Ursø,et al. The insulin-like growth factor-I receptor. Structure, ligand-binding mechanism and signal transduction. , 1994, Hormone research.
[102] B. Ursø,et al. The Insulin-Like Growth Factor-I Receptor , 1994, Hormone Research.
[103] J. Brange,et al. Insulin structure and stability. , 1993, Pharmaceutical biotechnology.
[104] T. Sasaoka,et al. Receptor binding and biologic activity of biosynthetic human insulin and mini-proinsulin produced by recombinant gene technology. , 1989, Diabetes research and clinical practice.
[105] A. King,et al. open access to scientific and medical research Open Access Full Text Article Glargine and detemir: Safety and efficacy profiles of the long-acting basal insulin analogs Review , 2022 .